PROMOTE mobile app to improve physical function and wellbeing in lung cancer survivors
Official title: Randomized Trial of a Digital Health Intervention to Improve Physical Function and Wellness of Lung Cancer Survivors
Run by Massachusetts General Hospital · NCT07227623 · Data updated 2026-11-12
This project tests whether the PROMOTE mobile app can help adults with stage I–III non-small cell lung cancer undergoing curative chemotherapy improve their physical function and overall wellbeing.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | Massachusetts General Hospital Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | February 6, 2026 |
| Main results expected | February 28, 2029 |
| Study ends | February 28, 2029 |
| Registry record updated | March 19, 2026 |
| Trial ID | NCT07227623 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with stage I–III non-small cell lung cancer who are within six weeks of starting curative-intent treatment that includes chemotherapy, have ECOG performance status 0–2, can use an English-language digital app, and receive primary cancer care at a participating site are ideal candidates.
✕Probably not a fit
Patients with significant uncontrolled psychiatric or cognitive disorders that preclude participation, those unable to use an English-language digital intervention, or patients not receiving curative-intent chemotherapy are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will randomize adults with stage I–III non-small cell lung cancer who are within six weeks of starting curative-intent chemotherapy (with or without immunotherapy) to use the PROMOTE digital health app or receive enhanced usual care consisting of health education materials. The PROMOTE app delivers behavioral support for physical activity, breathlessness and sleep management, and healthy eating, and collects patient-reported outcomes over the treatment period. The primary outcome is patient-reported physical function, with secondary outcomes including dyspnea, sleep disturbance, physical activity, eating behaviors, self-efficacy, mood symptoms, and quality of life. Investigators will also explore mediators and moderators to understand who benefits most from the intervention.
Why it matters
Potential benefit: If effective, PROMOTE could help lung cancer survivors increase activity, reduce breathlessness and sleep problems, and improve quality of life during and after curative treatment.
How similar studies have gone: Behavioral and digital health interventions have shown benefits for physical activity and symptom management in cancer and pulmonary populations, but applying a dedicated app to early-stage lung cancer survivorship care is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Diagnosis of stage I-III non-small cell lung cancer * Within six weeks of initiating treatment with curative intent that includes chemotherapy ± immunotherapy in the neo-adjuvant or adjuvant setting with surgery or as part of definitive chemoradiation * Eastern Cooperative Oncology Group Performance Status = 0-2 (i.e., fully active to at least ambulatory and up and about more than 50% of waking hours) * Ability to use a digital health intervention that includes verbal and written information in English * Ability to complete questionnaires in English or Spanish * Primary cancer care at one of the participating institutions Exclusion Criteria: * Significant uncontrolled psychiatric disorder or other co-morbid disease (e.g., dementia, cognitive impairment), which the treating oncology clinician reports would prohibit the patient's ability to participate in study procedures
Where it's running
-
Massachusetts General Hospital
Boston, Massachusetts, United States Recruiting
Study contacts
- Study coordinator: Joseph A. Greer, PhD
- Email: jgreer2@mgh.harvard.edu
- Phone: 617-643-2143
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nurse-led support for caregivers of older adults with advanced lung cancer
This study tests a nurse-led care and resource system to support older adults with advanced lung cancer and their family caregivers.
-
Structured nutrition plus exercise to improve fat and muscle in older adults with obesity
This 12-week trial tests whether a supervised diet plan plus exercise improves fat mass and muscle function more than usual diet and exercise in adults aged 50 and older with obesity and insulin resistance.
-
Frame Running to Improve Exercise and Participation for Children and Young People With Physical Disabilities
This project will try a 24-week Frame Running training program to see if it improves function, participation, and quality of life in 8–18-year-olds with cerebral palsy or other physical disabilities.
-
Keeping muscle and strength during tirzepatide weight loss with resistance exercise
This program will test whether adding a progressive resistance exercise program to tirzepatide helps overweight or obese women aged 25–50 keep muscle and physical function while losing weight.
-
Managing chemotherapy side effects with a smartphone symptom app plus telenursing
This trial tests whether a smartphone symptom-reporting app combined with a standardized telenursing program helps adults starting first-cycle chemotherapy for gastric, lung, breast, or colon cancer manage treatment side effects.
-
Tiered Palliative Care for Patients with Advanced Heart Failure or Cancer
This trial tests a home-based, tiered palliative care program to see if more personalized support improves symptoms and quality of life for adults with advanced heart failure or certain advanced cancers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.